| 000 | 01115 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513040210.0 | ||
| 264 | 0 | _c19930421 | |
| 008 | 199304s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 024 | 7 |
_a10.1097/00005344-199321001-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChabrier, P E | |
| 245 | 0 | 0 |
_aVascular remodeling and antihypertensive therapy: the example of cicletanine. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c1993 |
||
| 300 |
_aS50-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aArteries _xdrug effects |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 700 | 1 | _aEsanu, A | |
| 700 | 1 | _aBraquet, P | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 21 Suppl 1 _gp. S50-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-199321001-00008 _zAvailable from publisher's website |
| 999 |
_c7680556 _d7680556 |
||